Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Transmeta (TMTA)-The Monster That Could Slay Intel -- Ignore unavailable to you. Want to Upgrade?

To: Bill Fischofer who wrote (211)	11/2/2000 5:48:27 PM
From: The Phoenix	Read Replies (2) \| Respond to of 421

Well... between that and the IBM news I'm not sure sure that what we've been hearing from the company has been nothing but hype.... I wouldn't touch this thing.

To: Bill Fischofer who wrote (211)	11/3/2000 1:33:57 PM
From: William F. Wager, Jr.	Respond to of 421

Transmeta pumps up IPO price range By Bloomberg News November 3, 2000, 9:15 a.m. PT video \| update Transmeta, a chip developer with backing from investors including Paul Allen, George Soros and Sony, on Friday raised the price range of shares to $16 to $18 for its initial public offering, an indication of strong investor demand. Based on this price range for the 13 million shares Transmeta plans to sell, the IPO could raise $208 million to $234 million before expenses. The company filed in August to raise as much as $200 million in an IPO. On Oct. 2, it said it expected to sell shares at $11 to $13, raising $143.6 million after costs, based on a $12 share price. The shares are scheduled to be sold to institutional investors Monday after the stock market closes. Morgan Stanley Dean Witter and Deutsche Banc Alex Brown are arranging the sale. Other banks involved include Salomon Smith Barney, Banc of America Securities and SG Cowen Securities. Santa Clara, Calif.-based Transmeta, which has developed chips for laptop computers and other portable devices, will have 126.05 million shares outstanding after the IPO. Multiplying this by $18 a share would value Transmeta at about $2.2 billion. Transmeta has had losses of $119.4 million to date, according to its IPO filing. The company had $358,000 of revenue from products in the first half of this year, almost five times its $74,000 of product revenue a year earlier. In the year-earlier period, it also received $5 million of one-time technology licensing fees from IBM and Toshiba, the filing said. Transmeta introduced its Crusoe chip last January. The chip uses software to perform tasks usually run by millions of tiny transistors. The chips can be configured and upgraded more easily than pure hardware chips and require less battery power. The company has said those features can help produce smaller, lighter, and more affordable computers and portable devices. The chips are manufactured for Transmeta by IBM, which said this week it decided not to use Transmeta processors in one model of its ThinkPad notebook computers, a line that uses mainly Intel chips. IBM said it will continue to manufacture Transmeta's Crusoe chip. Sony, Fujitsu and NEC are selling notebook computers using Crusoe. Other Transmeta backers include Compaq Computer, Taiwan's Quanta Computer and Institutional Venture Partners. Its developers include Linus Torvalds, creator of the Linux operating system that competes with Microsoft's Windows.